$1.75
0.084.79%
Last update: Oct 2, 7:47 AM
$1.74
0.074.19%

PMV Pharmaceuticals (PMVP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.40 | $-0.39 | $-0.40 | $-0.40 |
| Actual | $-0.34 | $-0.34 | $-0.34 | $-0.40 |
| Surprise | +15.0% | +12.8% | +15.0% | 0.00% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.33 | $-0.29 | $-0.26 | $-0.22 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.34 | $-0.40 | 15.0 % |
| Q1 | May 12, 2026 | $-0.34 | $-0.39 | 12.8 % |
| Q4 | Mar 6, 2026 | $-0.34 | $-0.40 | 15.0 % |
| Q3 | Nov 12, 2025 | $-0.40 | $-0.40 | 0.00 % |